Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 124628
Published online Nov 15, 2026. doi: 10.4239/wjd.124628
Published online Nov 15, 2026. doi: 10.4239/wjd.124628
Table 2 Comparisons of clinical characteristics and outcomes among diabetes mellitus-community-acquired pneumonia patients, mean ± SD/n (%)/median (interquartile range)
| Characteristics | NSCAP (n = 61) | SCAP (n = 26) | P value |
| Sex, male | 38 (62.30) | 19 (73.10) | 0.333 |
| Age ≥ 65 years | 33 (54.10) | 22 (84.62) | 0.007 |
| Underlying disease(s) | |||
| Chronic heart diseases | 26 (42.62) | 17 (65.38) | 0.052 |
| Hypertension | 43 (70.49) | 19 (73.08) | 0.807 |
| Chronic renal diseases | 4 (6.56) | 1 (3.85) | 1.000 |
| Cerebrovascular diseases | 9 (14.75) | 13 (50.00) | 0.001 |
| Chronic pulmonary diseases | 7 (11.48) | 2 (7.69) | 0.899 |
| Laboratory results | |||
| WBC (× 109/L) | 7.47 (6.11-10.70) | 12.46 (9.51-14.88) | < 0.001 |
| NEU (× 109/L) | 4.86 (3.69-7.87) | 10.69 (7.50-12.93) | < 0.001 |
| LYM (× 109/L) | 1.41 (0.96-2.01) | 0.92 (0.52-1.64) | 0.058 |
| NLR | 3.48 (1.95-8.36) | 10.77 (5.26-40.28) | < 0.001 |
| CRP (mg/L) | 39.18 (10.60-117.67) | 51.14 (16.40-105.65) | 0.330 |
| PCT (μg/L) | 0.09 (0.05-0.25) | 0.38 (0.17-1.59) | 0.003 |
| ALB (g/L) | 37.39 (32.14-40.23) | 32.81 ± 5.23 | 0.007 |
| Cr (μmol/L) | 72.66 (63.27-86.53) | 100.80 (66.92-153.10) | 0.009 |
| BUN (mmol/L) | 5.62 (4.70-7.07) | 9.70 (8.13-19.19) | < 0.001 |
| Oncostatin M (pg/mL) | 26.89 (11.03-58.93) | 56.29 (35.59-139.19) | 0.001 |
| Interleukin-6 (pg/mL) | 4.74 (2.77-13.84) | 11.00 (4.71-17.65) | 0.020 |
| Interleukin-8 (pg/mL) | 14.91 (12.24-23.02) | 26.85 (20.19-49.61) | 0.001 |
| CURB-65 score | 1 (0-1) | 3 (2-3) | < 0.001 |
| PSI score | 71.00 (59.50-87.50) | 137.50 (121.25-156.75) | < 0.001 |
| In-hospital mortality | 0 (0) | 4 (15.38) | 0.007 |
| 1-year mortality | 2 (3.28) | 15 (57.69) | < 0.001 |
- Citation: Sun Y, Li Q, Wang H, Gu MH, Teng PK, Zhang XY, Han XD, Liu XD. Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus. World J Diabetes 2026; 17(11): 124628
- URL: https://www.wjgnet.com/1948-9358/full/v17/i11/124628.htm
- DOI: https://dx.doi.org/10.4239/wjd.124628